地球化学学报(英文版)(Acta Geochimica) (原:中国地球化学(英文版)(Chinese Journal of Geochemistry) 知网万方维普
- CSCD
- 高T2
- EI(中国2024)
- 主管单位:
中国科学院地球化学研究所
- 主办单位:
中国科学院地球化学研究所、中国矿物岩石地球化学学会
- 国际刊号:
2096-0956
- 国内刊号:
52-1161/P
- 学科分类:
- 字数:
24000-58000
- 有无基金:
/有基金 100.0%
- 周期:
CN外文-双月刊
- 特殊属性:
第一批认定学术期刊
- 电话:
0851-85891358(202304期)
- 邮箱:
geochem@vip.gyig.ac.cn(202304期)
- 复合因子:
0.648
- 综合因子:
0.464
- 收录:
知网,万方,维普
- 级别:
CSCD,高T2,EI(中国2024)
期刊简介
《地球化学学报(英文版)(Acta Geochimica) (原:中国地球化学(英文版)(Chinese Journal of Geochemistry)》期刊已被查看: 次
更新频次
单位占比
一作占比
/有基金-100.0%投稿指南
1、投稿方式:在线投稿。
2、刊内网址:(202304期)
http://www.springer.com/11631
https://www.editorialmanager.com/cjog(投稿系统)
3、主办单位网址:http://www.gyig.cas.cn/xscbw_/
(中国科学院地球化学研究所)
4、出刊日期:双月刊,逢双月出版。
2023年8月29星期二
《地球化学学报(英文)》投稿指南
Submission guidelines
【官网信息】
Instructions for Authors
Editorial procedure
Double-blind peer review
This journal follows a double-blind reviewing procedure. Authors are therefore requested to submit:
A blinded manuscript without any author names and affiliations in the text or on the title page. Self-identifying citations and references in the article text should be avoided.
A separate title page, containing title, all author names, affiliations, and the contact information of the corresponding author. Any acknowledgements, disclosures, or funding information should also be included on this page.
Manuscript Submission
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher will not be held legally responsible should there be any claims for compensation.
Permissions
Authors wishing to include figures, tables, or text passages that have already been published elsewhere are required to obtain permission from the copyright owner(s) for both the print and online format and to include evidence that such permission has been granted when submitting their papers. Any material received without such evidence will be assumed to originate from the authors.
Online Submission
Please follow the hyperlink “Submit manuscript” on the right and upload all of your manuscript files following the instructions given on the screen.
Please ensure you provide all relevant editable source files. Failing to submit these source files might cause unnecessary delays in the review and production process.
Title Page
Please make sure your title page contains the following information.
Title
The title should be concise and informative.
Author information
The name(s) of the author(s)
The affiliation(s) of the author(s), i.e. institution, (department), city, (state), country
A clear indication and an active e-mail address of the corresponding author
If available, the 16-digit ORCID of the author(s)
If address information is provided with the affiliation(s) it will also be published.
For authors that are (temporarily) unaffiliated we will only capture their city and country of residence, not their e-mail address unless specifically requested.
Abstract
Please provide an abstract of 150 to 250 words. The abstract should not contain any undefined abbreviations or unspecified references.
For life science journals only (when applicable)
Trial registration number and date of registration
Trial registration number, date of registration followed by “retrospectively registered”
Keywords
Please provide 4 to 6 keywords which can be used for indexing purposes.
Declarations
All manuscripts must contain the following sections under the heading 'Declarations'.
If any of the sections are not relevant to your manuscript, please include the heading and write 'Not applicable' for that section.
To be used for all articles, including articles with biological applications
Funding (information that explains whether and by whom the research was supported)
Conflicts of interest/Competing interests (include appropriate disclosures)
Availability of data and material (data transparency)
Code availability (software application or custom code)
Authors' contributions (optional: please review the submission guidelines from the journal whether statements are mandatory)
Additional declarations for articles in life science journals that report the results of studies involving humans and/or animals
Ethics approval (include appropriate approvals or waivers)
Consent to participate (include appropriate statements)
Consent for publication (include appropriate statements)
Please see the relevant sections in the submission guidelines for further information as well as various examples of wording. Please revise/customize the sample statements according to your own needs.
Article Highlights
Please provide three short bullet points (maximum of 120 characters each) summarizing the key findings and implications of the paper. These should be presented in non-technical language and not repeat verbatim text found in the abstract. They should be placed beneath the abstract under the heading of ‘Article Highlights’.
Text
Text Formatting
Manuscripts should be submitted in Word.
Use a normal, plain font (e.g., 10-point Times Roman) for text.
Use italics for emphasis.
Use the automatic page numbering function to number the pages.
Do not use field functions.
Use tab stops or other commands for indents, not the space bar.
Use the table function, not spreadsheets, to make tables.
Use the equation editor or MathType for equations.
Save your file in docx format (Word 2007 or higher) or doc format (older Word versions).
Manuscripts with mathematical content can also be submitted in LaTeX.
LaTeX macro package (Download zip, 188 kB)
……
更多详情:
https://www.springer.com/journal/11631/submission-guidelines
中国全科医学发文选摘
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
《地球化学学报(英文版)(Acta Geochimica) (原:中国地球化学(英文版)(Chinese Journal of Geochemistry)》同类天文地球科学期刊
-
热带海洋学报
北核,CSCD,科核,高T2,武B+
CN中文-双月刊影响因子0.978
-
海洋地质前沿(原:海洋地质动态)
北核,CSCD,科核,高T2
CN中文-月刊影响因子1.113
-
空间控制技术与应用
北核,CSCD,科核,武B+
CN中文-双月刊影响因子1.174
-
沉积与特提斯地质
北核,科核,CSCD扩,高T2,武B+
CN中文-季刊影响因子2.266
-
海洋通报
北核,CSCD,科核,高T2,武B+
CN中文-双月刊影响因子1.295
-
地震研究
北核,科核,CSCD扩,高T2,高T3,CACJ-核心
CN中文-季刊影响因子1.467
-
中国岩溶
北核,科核,CSCD扩,高T2,武B+
CN中文-双月刊影响因子1.833
-
大气科学学报(原:南京气象学院学报)
北核,CSCD,科核,高T2,武B+
CN中文-双月刊影响因子1.883
常见问题
-
哪些期刊可以用来评职称?
1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。
-
你们的服务可以保证文章被发表吗?
期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。
-
请问发表一篇期刊的费用是多少?
期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。
-
如果发表不成功可以退款吗?
如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。
-
请问文章发表需要多长时间?
不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。
-
期刊发表能加急见刊吗?
为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。